Vildagliptin is a new type of oral hypoglycemic drug, which mainly promotes insulin secretion by increasing GLP-1 substance in the body to exert hypoglycemic effect. Similar drugs include selegiline, alogliptin, ligustine, saxagliptin and so on. The above drugs have the same mechanism of action, but statins are taken in slightly different ways, especially with different requirements for liver and kidney function. If you want to change glucose-lowering drugs, especially for diabetic patients with liver and kidney function damage, it is best to go to a regular hospital to ask a professional endocrinologist to change the treatment plan after completing the relevant examinations and take the medication according to the doctor’s instructions, and do not stop or change the medication without authorization.